These rankings are based on data from October 2025
Company
GT Apeiron Therapeutics
Years in business
- 6
Number of employees
- 11-50 employees
Country
- United States
Apeiron Therapeutics is a clinical-stage biopharmaceutical company developing biomarker-driven, AI-enabled small molecule therapies for cancer. The company leverages structure-based, AI-driven drug design to build a pipeline of targeted treatments, aiming for best-in-class and first-in-class oncology candidates that address unmet medical needs.
API Availability
- Unknown
Pricing
unknown
Position of GT Apeiron Therapeutics on sub rankings
October 2025
Drug discovery & development - Overall
13 out of 58
United States - Overall
2,415 out of 16,378
Drug discovery & development - Overall
13 out of 58
United States - Overall
2,415 out of 16,378
Industries
health & sports
research & development
Company
GT Apeiron Therapeutics
Years in business
- 6
Number of employees
- 11-50 employees
Country
- United States
Insights
